Podcasts about stanford byers center

This week, we revisit our interview with Nick Damiano. Nick is a serial entrepreneur focused on solving unmet needs to improve patient care. He is currently CEO & Founder of Andromeda Surgical, which is developing autonomous robots for safer, better, more efficient surgery. Before that, he was CEO & Co-Founder of Zenflow, where he co-invented a novel implant for BPH (enlarged prostate) and led the product from inception through multiple clinical trials to commercial readiness, raising over $60M in funding. He was also CTO & co-founder at Nurep, later re-branded as Avail MedSystems. He was the key architect of the company's remote surgical support product for operating rooms that is now used in hundreds of medical facilities. Nick earned his M.S. and B.S. with Distinction in Management Science & Engineering from Stanford University and was an Innovation Fellow at Stanford Byers Center for Biodesign. He was the first medtech founder to be funded by Y Combinator twice and actively advises startups through StartX, UCSF Rosenman Institute, and Nucleate Bio. He also dabbles on the investor side as a Venture Partner at Pioneer Fund.

Jonathan is joined by Joshua Makower, Director and Co-Founder of the Stanford Byers Center for Biodesign, Stanford University, California, USA. The pair navigate fascinating themes, from Makower's passion for music and his band, Still Trust, to innovative strategies for controlling rising healthcare costs through innovation. Makower offers perspectives on AI in healthcare, and the associated challenges with regulating these new technologies. Use the following timestamps to navigate the topics discussed in this episode: (00:00)-Introduction  (03:05)-A passion for music  (06:11)-From the Massachusetts Institute of Technology (MIT) to medical school  (08:50)-The Biodesign process  (19:37)-Driving technology from mind to marketplace  (23:25)-Doctors engaging with industry  (27:52)-The ExploraMed incubator  (31:07)-Josh's current work  (34:27)-The importance of failure  (36:16)-Perspectives on artificial intelligence in healthcare  (39:05)-Healthcare innovation horizons  (40:37)-Medical technology regulation  (46:00)-Josh's three wishes for the future of healthcare 

“You can be successful as an innovator, even as a physician or any other background you have, as long as you follow the process and really focus on the needs. That's the key.” - Dr Josh Makower, Director and Co-Founder of the Stanford Byers Center for Biodesign.In this episode, Dr Joshua Makower discusses his newest medical device approval "Moximed" and how his multi-disciplinary education of engineering, medicine and business has supported his successful career as an inventor. He goes on to highlight how clinicians and healthcare systems need to embrace innovation to solve some of our biggest challenges. Dr Makower puts forward how lessons working on innovation at Pfizer influenced the Biodesign approach to innovation. Finally, he covers the policy and investment landscape for progressing healthcare innovation.Follow Dr Makower* Twitter/X* LinkedInAbout the guest:Josh Makower, MD is the Boston Scientific Applied Bioengineering Professor of Medicine and of Bioengineering at the Stanford University Schools of Medicine and Engineering, and is the Director and Co-Founder of the Stanford Byers Center for Biodesign, and Founder of Stanford's Biodesign Policy Program.  Josh also serves as a Special Partner on New Enterprise Associate's healthcare team supporting their medtech/healthtech practice.  Lastly, Josh is the Founder and Executive Chairman of ExploraMed, a medical device incubator that has created 10 companies over the past 20 years. Josh currently serves on the board of directors for DOTS Devices, ExploraMed, Allay Therapeutics, Lungpacer, Moximed, Willow Innovations, SetPoint Medical, X9 and Coravin. Josh holds over 300 patents and patent applications for various medical devices in the fields of cardiology, ENT, general surgery, drug delivery, plastic surgery, dermatology, aesthetics, obesity, orthopedics, women's health and urology.Additional resources mentioned in the podcast:* Moximed* Biodesign at Stanford* Book - Biodesign: The Process of Innovating Medical TechnologiesContact Information for the Podcast: If you have any feedback, questions or if you'd like to get in touch, reach out at jono@clinicalchangemakers.comIntro and Out Music Attribution: Music by AudioCoffee from Pixabay This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.clinicalchangemakers.com

This episode features Bob Rebitzer, National Advisor, Manatt Health & Senior Advisor, Stanford Byers Center for Biodesign & Jim Rebitzer, Peter and Deborah Wexler Professor at Boston University's Questrom School of Business. Here, they discuss insights into their backgrounds & new book they've co-authored “Why Not Better and Cheaper? Healthcare and Innovation”, advice for healthcare leaders looking to innovate, and more.

Integrating biodesign principles can drive innovative breakthroughs in medical device technology. But what exactly is biodesign, and how can medtech companies utilize it to drive innovation?On this week's Medical Alley Podcast, Greg Johnson of Veranex and Todd Brinton of Edwards Lifesciences join to share more about biodesign and how they've utilized it at their respective organizations. Both have experience the Stanford Byers Center for Design, which was co-founded by former Medical Alley Podcast guest Josh Makower.Tune in to learn more about the concept of biodesign — a structural process for thinking about innovation — and hear Greg and Todd share their visions for the future of biodesign in medtech.Follow Medical Alley on social media on LinkedIn, Facebook, Twitter and Instagram.

CardinalKit (now Spezi) is an open-source framework for Digital Health Applications and Research. They were recently featured in the news for releasing HealthGPT, an experimental iOS app that lets you query your health data. Spezi is housed in the Stanford Byers Center for Biodesign and directed by Oliver Aalami, MD with Vishnu Ravi, MD as lead architect. Also joining us on this interview is postdoc Paul Schmiedmayer, PhD. Spezi provides a suite of tools to build modern, interoperable digital health tools from the ground up, from the app itself to storing and analyzing collected data in the cloud. It is designed to accelerate rapid prototyping of digital health applications by reducing costs by as much as 75% (~$150,000) and timelines by 12 months. Host: David Wu Twitter: @davidjhwu  Audio Producer + Video Editor + Art: Saurin Kantesaria Instagram: saorange314 Social Media: Nikhil Kapur Time Stamps: 00:58 - The expertise behind Spezi (CardinalKit) 08:03 - Healthcare has a lack of data standardization + Why you should know about HL7 FHIR 14:13 - How did Spezi (CardinalKit) become what it is today? 18:26 - Drink Spezi! 19:53 - Making code/healthcare data more modular and user-friendly 26:40 - Translating a med student's sensor research to a useable device for kids with cerebral palsy 31:20 - From a $40,000 eczema patch test in clinic to a completely at-home test 35:45 - Using healthGPT to make health data easy to understand for patients (LLM on FHIR) 42:35 - How do you deal with privacy issues? 49:33 - What do you think the future of AI in medicine will look like in 10-20 years? 52:00 - Applications where using only an LLM doesn't always work (a case for hybrid systems) 55:30 - What brings you joy? 58:43 - What makes a successful digital health team?

Dr. Josh Makower is a Professor of Medicine & Bioengineering at Stanford University and is also the Director & Co-Founder, Stanford Byers Center for Biodesign. He joined this week's Medical Alley Podcast for a wide-ranging conversation. Dr. Makower joined Medical Alley's Frank Jaskulke to discuss his Perfect Storm presentation, share more about the importance of policy work with regards to healthcare innovation, talk about the Stanford Biodesign program, and much more.

This episode is sponsored by @MedicalExpertWitness.com.  The episode features Dr. Al'ai Alvarez discussing the Stanford Fulfillment Model and its relevance to medical practices. Dr. Alvarez shares his training experience and how he ended up at Stanford. He highlights the three key aspects of the Stanford professional fulfillment model: culture of wellness, efficiencies of practice, and personal resilience. The discussion revolves around the importance of creating an environment that fosters autonomy, belonging, and competence, as well as the need for meaningful efforts from institutions to support clinicians' professional fulfillment. Looking for something specific? Here you go! 00:03:29 Stanford fulfillment model promotes professional fulfillment. 00:05:41 Responsibility for burnout lies with institutions. 00:11:03 Physicians experience imposter phenomenon. 00:17:11 Normalize self-care in medicine. 00:21:28 Recognize and value team contributions. 00:28:40 Practice self-compassion and gratitude. 00:33:01 Self-compassion is essential for resilience. 00:36:28 Practice self-compassion and celebrate achievements. 00:42:44 Intersection of wellness and DEI. Bio/links! Al'ai Alvarez, MD, is a prominent national leader and educator in wellness, diversity, equity, and inclusion. He holds the position of Clinical Associate Professor of Emergency Medicine (EM) and serves as the Well-Being Director at Stanford Emergency Medicine. Dr. Alvarez's focus lies in humanizing physician roles and teams, harnessing individual human potential within high-performance contexts by optimizing the connections between Process Improvement, Recruitment, and Well-being. He is also associated with the Stanford Byers Center for Biodesign as a 2021-2022 Faculty Fellow. Previously, Dr. Alvarez served as an associate program director in the Stanford Emergency Medicine Residency Program for five years, emphasizing the intersectionality of resident well-being with performance improvement, patient experience, quality and safety, diversity, equity, inclusion, and medical education. His contributions include co-founding the largest diversity mentoring initiative in Emergency Medicine through ACEP and EMRA. Additionally, Dr. Alvarez chairs Stanford WellMD's Physician Wellness Forum and directs Stanford's Physician Resource Network (PRN) Support Program, offering vital peer-to-peer support for faculty and trainees. As a sought-after speaker, he delivers grand rounds and lectures at national conferences, addressing self-compassion, physician well-being, high-performance teams, leadership capacity, and mentorship to enhance diversity and inclusion. Dr. Alvarez's remarkable dedication and contributions have earned him prestigious awards, such as the 2019 ACEP DIHE Distance and Impact Award and the 2022 John Levin Leadership Award at Stanford Health Care. Connect with Dr. Alvarez on his LinkedIn.  Did ya know…  You can also be a guest on our show? Please email me at brad@physiciansguidetodoctoring.com to connect or visit www.physiciansguidetodoctoring.com to learn more about the show! Socials: @physiciansguidetodoctoring on FB  @physicianguidetodoctoring on YouTube @physiciansguide on Instagram and Twitter

This week we interview Nick Damian. Nick is a serial entrepreneur focused on solving unmet needs to improve patient care. He is currently CEO & Founder of Andromeda Surgical, which is developing autonomous robots for safer, better, more efficient surgery. Before that, he was CEO & Co-Founder of Zenflow, where he co-invented a novel implant for BPH (enlarged prostate) and led the product from inception through multiple clinical trials to commercial readiness, raising over $60M in funding. He was also CTO & co-founder at Nurep, later re-branded as Avail MedSystems. He was the key architect of the company's remote surgical support product for operating rooms that is now used in hundreds of medical facilities. Nick earned his M.S. and B.S. with Distinction in Management Science & Engineering from Stanford University and was an Innovation Fellow at Stanford Byers Center for Biodesign. He was the first medtech founder to be funded by Y Combinator twice and actively advises startups through StartX, UCSF Rosenman Institute, and Nucleate Bio. He also dabbles on the investor side as a Venture Partner at Pioneer Fund.

Meet Josh MakowerJosh Makower, M.D., is the Boston Scientific Applied Bioengineering Professor of Medicine and of Bioengineering at the Stanford University Schools of Medicine and Engineering, and is the Director and Co-Founder of the Stanford Byers Center for Biodesign, and Founder of Stanford's Biodesign Policy Program. Key Insights:Josh holds over 300 patents, and believes that innovation is a process than can be taught.  How to improve global health? Josh believes that innovation can be learned deliberately, and that those who practice it according to his process, will get good at it. Two Modes. The innovator must first consider all possibilities, even “wild ideas,” and then switch gears, to identify dead ends as rapidly as possible. Teaching Policymakers. In addition to teaching aspiring innovators, Josh believes that educating the next generation of policymakers is a crucial undertaking. This episode was made possible by our partnership with Edwards Lifesciences. Relevant Links:Read more about Josh MakowerRead more about Stanford's Biodesign Policy Program

The National Institutes of Health spends about $42 billion on medical research each year, but less than one-eighth of that money is spent specifically on women's health. That may come as a bit of a shock, given that women make up a majority – about 51% – of the population. This underserved market is a huge economic opportunity for med tech companies.That's what Holly Rockweiler discovered as a Fellow at the Stanford Byers Center for Bio Design. So she put her background in biomedical engineering to work and started Madorra Medical, developing solutions to improve the vaginal atrophy and dryness that women experience after menopause or breast cancer. Madorra's flagship product is a handheld home-use device that uses ultrasound to rekindle the body's natural moisture-producing capability. The FDA has granted it breakthrough device designation The first randomized trial has been published, and a second one is on the way, and the company is now working toward the next set of data. Here in Episode #24, Madorra CEO Holly Rockweiler and Andy Rodgers talk about how that data is helping to blaze new trails in women's health. Need to know: There was a commercial about menopause in this year's Super Bowl (Astellas Pharma). That simple fact signals a new era in women's health.  Fundraising can be the most difficult part of bringing a new product to market, and it never goes away. Investors want to know what data has been collected, what payer requirements are, and to see a clear path to market. Piggyback on existing data when you can. For Madorra, there was substantial literature and technology using ultrasound in other therapies, data on vaginal blood flow from sexual arousal studies, and existing ultrasound devices that could be modified to show proof of concept. The nitty-gritty:Vaginal dryness resulting from vulvovaginal atrophy (VVA) affects over half of post-menopausal women and is also common among breast cancer survivors due to treatments that cause estrogen levels to drop. Symptoms include soreness, irritation, pain, increased urinary tract and yeast infection rates, and pain with sexual intercourse. Today, the standard treatment for menopausal symptoms is estrogen therapy. But that comes with risks: breast cancer, heart attack, and stroke. The quandary for doctors and patients alike is whether the benefits of pharmaceutical treatment outweigh the risks. For some patients, the risks are too significant and estrogen therapy is not recommended.   By putting data to work, Madorra created an ultrasound solution that stimulates natural moisture production and eliminates these risks. Madorra's hand-held external device, used on regular basis for 8 minutes, has been producing significant results in 1 to 3 weeks.  The device is shaped to be intuitive as possible to fit naturally and is used with disposable proprietary hydrogel. Safety is always a key issue, and the wide variety of literature on ultrasound therapies – including the fact that it's used on pregnant women – has instilled confidence in patients and clinicians alike. Data that made the difference:Market data from the Stanford BioDesign program helped Rockweiler learn to do an analysis of unmet needs, stakeholders, and market dynamics before taking the big leap.An Institutional Review Board (IRB) feasibility study helped in initial development.Pre-existing data on ultrasound showed that ultrasound therapy in other uses improved blood flow to treated areas. This key finding indicated that it might work on thin friable vaginal tissue as well.Patient data revealed how the condition feels to patients and what they wanted in a product.Bench studies and computer simulations proved invaluable in prototyping.This story is not only compelling because of the ingenious device itself, but it also reveals a broader story about opportunities in the underserved market of women's health.Interesting links:https://www.madorra.com/https://www.ispot.tv/ad/1VAi/astellas-pharma-super-bowl-2023-whats-vms

Audible Bleeding editor Wen (@WenKawaji) is  joined by JVS-VS Associate Editor Dr. Jose Diaz, JVS Assistant Editor Dr. Paul Dimuzio (@pdimuziomd) , and JVS Editor-in-Chief Dr. Thomas Forbes (@TL_Forbes) to discuss two great articles in the JVS family of journals.  They're joined by Dr. Oliver Aalami and Dr. Terence Ryan, authors of each of the papers discussing SVS supervised exercise therapy and two proteins (S100A8 and S100A9) that play an integral role in the ischemic limb pathophysiology.  “Use of an app-based exercise therapy program including cognitive behavioral techniques for the management of intermittent claudication” by Aalami et al. “S100A8 and S100A9 are elevated in chronically threatened ischemic limb muscle and induce ischemic mitochondrial pathology in mice” by Ryan et al. Show Guests: Dr. Oliver Aalami (@DrAalami) is a clinical professor of surgery at Stanford University. He is also the director of Stanford Byers Center for Biodesign since 2018.  Dr. Terence Ryan (@TerenceRyan_PhD) is an assistant professor on tenure track in the department of applied physiology and kinesiology at the University of Florida. Dr. Ryan's work focuses on understanding the molecular pathways that regulate muscle and vascular responses to environmental and endogenous stressors.    Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and #jointheconversation.

Josh Makower, MD, is the Boston Scientific Applied Bioengineering Professor of Medicine and of Bioengineering at the Stanford University Schools of Medicine and Engineering, and is the director and co-founder of the Stanford Byers Center for Biodesign. In this conversation with Stanford adjunct lecturer Ravi Belani, Makower unpacks the center's biodesign process and encourages entrepreneurs to find opportunities in the world of health technology innovation.--------------------Stanford eCorner content is produced by the Stanford Technology Ventures Program. At STVP, we empower aspiring entrepreneurs to become global citizens who create and scale responsible innovations.CONNECT WITH USTwitter: https://twitter.com/ECorner LinkedIn: https://www.linkedin.com/company/stanfordtechnologyventuresprogram/ Facebook: https://www.facebook.com/StanfordTechnologyVenturesProgram/ YouTube: https://www.youtube.com/user/ecorner LEARN MOREeCorner Website: https://ecorner.stanford.edu/STVP Website: https://stvp.stanford.edu/Support our mission of providing students and educators around the world with free access to Stanford University's network of entrepreneurial thought leaders: https://ecorner.stanford.edu/give.

Josh Makower, MD, is the Boston Scientific Applied Bioengineering Professor of Medicine and of Bioengineering at the Stanford University Schools of Medicine and Engineering, and is the director and co-founder of the Stanford Byers Center for Biodesign. In this conversation with Stanford adjunct lecturer Ravi Belani, Makower unpacks the center's biodesign process and encourages entrepreneurs to find opportunities in the world of health technology innovation.

Al'ai Alvarez, MD aka LA is a national leader and educator on Wellness and Diversity, Equity, and Inclusion. He is a clinical assistant professor of Emergency Medicine and the Director of Well-Being at Stanford Emergency Medicine. He co-leads the Human Potential Team and serves as the Fellowship Director of the Stanford EM Physician Wellness, and Co-Chair of the Stanford WellMD's Physician Wellness Forum. His work focuses on humanizing physician roles as individuals and teams through the harnessing of our individual human potential in the context of high-performance teams. This includes optimizing the interdependence between Process Improvement (Quality and Clinical Operations), Recruitment (Diversity), and Well-being (Inclusion). Currently, he is one of the 2021-2022 Faculty Fellows at the Stanford Byers Center for Biodesign.  Andrew Petrosoniak MD is a trauma team leader and emergency physician at St. Michael's Hospital in Toronto, Canada. He's an assistant professor at the University of Toronto and he leads the translational simulation program at St. Michael's Hospital. His research focuses on the use of in situ simulation and design thinking to support human-centered care. He's also co-principal at Advanced Performance Healthcare Design, a firm that consults with hospitals, start ups and high stake industries using simulation to improve decision making and inform the design of systems, spaces and teams. White paper on simulation informed design. In 2004, Patrick MacLeamy drew a set of curves based on a pretty self-evident observation: an architectural project becomes more difficult to change the more developed it becomes. For this earth-shattering revelation MacLeamy named the curve after himself (although the title should probably go to Boyd Paulson who drew the curve much earlier [see Noel's comment to this post]). You have probably seen the graph before. It gets trotted out in every slide deck promoting BIM / IPD / or early-stage environmental analysis.  The key point is that architects expel their effort at a time when design changes are relatively costly. MacLeamy and his disciples advocate shifting design effort forward in the project, front loading it, in order to reduce the cost of design changes.

“I always go in directions where everyone thinks you can't do something. I'm not a follower. I like to blaze new ground, and I like to take on hard challenges.” When it comes to biodesign and medical device innovation, Josh Makower takes a different approach. Unimpressed by incremental improvements and copycat products, Josh and his team insist on filling gaps in the market by pioneering breakthrough solutions where true need exists — all while considering the full length and breadth of the patient/physician experience and relationship. It's this methodology that has shaped his highly impressive career as a biotech, inventor, founder, entrepreneur, investor, and professor — a career marked by serial success, in which innovation and breakthroughs are the expected norm. Among numerous other titles and credits, he is a Stanford professor of Medicine & Bioengineering, Director and Co-founder of the Stanford Byers Center for Biodesign, and Founder and Exec Chair of medical device incubator ExploraMed. In his hour-long interview by Dr. Grant Stevens, Mr. Makower takes us through a half dozen of his most notable successes, each of which would suffice to define a career. He also delves into the future of biodesign and unpacks how his recent entry into aesthetics could entirely transform the treatment of cellulite. Tune in now to hear it for yourself.

“In addition to the vast impact his inventions have had, I believe Paul's multifaceted legacy will be kept by his influence on the innovators of today and generations well into the future." The iconic Paul Yock, MD, joins Andrew Cleeland as he provides a glimpse into his stellar career as an accomplished physician, innovator and educator. Paul is the Martha Meier Weiland Professor of Medicine, founding co-chair of Stanford's department of bioengineering and founder of the Stanford Byers Center for Biodesign. He is known for his inventions that have improved care for millions of people around the world, including the Rapid Exchange stenting and balloon angioplasty system and the Smart Needle. Resources: Fogarty Innovation: www.fogartyinnovation.org MedTech Trailblazers podcast: www.medtechtrailblazers.libsyn.com Paul Yock, MD, bio: www.profiles.stanford.edu/paul-yock Stanford Byers Center for Biodesign: www.biodesign.stanford.edu

Anyone who's spent time in the medtech field knows that the name Josh Makower is synonymous with innovation, as he has blazed numerous trails for new technologies and therapies alike. Josh cut his teeth at Pfizer, then went on to become the quintessential entrepreneur, founding eight medtech companies in a variety of clinical specialties including minimally invasive vascular surgery; ear, nose and throat (ENT) issues; and women's health. He created an incubator, ExploraMed, to bring promising technologies to market and has been and still is a general partner at NEA, a global venture capital firm that funds innovation; and is the incoming director of the Stanford Byers Center for Biodesign. In this episode, we discover the personality behind the genius and find out what drives his passion and made him who he is today.   Resources Josh Makower on LinkedIn | Twitter

This week we revisit our conversation with Josh Makower, who was recently selected as the new Director of the Stanford Byers Center for Biodesign. Josh is the Founder and Executive Chairman of ExploraMed, a medical device incubator. He is also a General Partner at NEA and leads the MedTech/Healthtech practice. He also serves at the Stanford University Medical School as an Adjunct Professor of Medicine and is Co-Founder of Stanford's Biodesign Innovation Program. He received an MBA from Columbia University, an MD from the NYU School of Medicine, and a bachelor's degree in Mechanical Engineering from MIT.

Nirvik finished high school in Singapore where he was able to complete as many college prerequisites as he could and participated in rigorous extra curricular activities related to his interest in computer science. He is currently completing his double degree in Computer Science and Classical Languages from Stanford University. His high school experiences allowed him to get placed into advanced sequence classes freshman year. Continuing on, he was also able to work as a teaching assistant for beginner comp sci classes. He is currently working as a researcher for TockOS. Additionally, he is also a research assistant for the Stanford Byers Center for Biodesign where he is creating an advanced care planning platform for the Stanford Hospital system. He hopes to continue on to academia in the future.

Amanda French is the Co-Founder and CEO of Emme, a contraception company home to the Emme Smart Case system that automatically tracks when a user takes their pill and reminds them when you don't, so they can live stress-free. Amanda has over a decade of experience bringing innovative products to the market with a focus on women’s health, including a product that facilitated the distribution of antiretrovirals to mothers in the developing world which was recognized by Hilary Clinton and won USAID’s Saving Lives at Birth Grand Challenge. She also developed heart valve technology as an R&D engineer with Edwards Lifesciences and went on to develop state-of-the-art hearing aids at Earlens. Amanda was a 2016-2017 Innovation Fellow at the Stanford-Byers Center for Biodesign, and a Ferolyn Fellow in 2018-2019 with the Fogarty Institute for Innovation. She holds a BS in Mechanical Engineering from Duke University. We discussed the barriers to accessing contraception, fundraising by grants, research and investment in FemTech. Check out the Emme at www.emme.com Rate, Review & Subscribe!

Paul G. Yock, MD, MA, presented the C. Walton Lillehei Lecture during the STS Annual Meeting. In his lecture, “The (Radically) Changing Landscape of Medical Technology Innovation,” Dr. Yock encouraged participants to view innovation as a discipline—one that can be taught, practiced, and recreated. He acknowledged, though, that comprehensive innovation can be difficult in the health care setting because it involves multiple stakeholders. He likened the “user” in this scenario to an “eight-headed monster.” Dr. Yock said that to manage this complexity, the biodesign process should utilize the overarching principles of “identify,” “invent,” and “implement,” which—like design thinking—places the invention step in the middle. Dr. Yock is the founder and director of the Stanford Byers Center for Biodesign in California. 

In this episode we spoke to Dr. Thomas Krummel, the immediate past Chief of Surgery at Stanford University School of Medicine and the current co-director of Stanford Byers Center for Biodesign. We asked him about healthcare leadership, and how to transform any idea into a reality. Facebook: https://www.facebook.com/thatmedicnetwork Instagram: https://www.instagram.com/thatmedicnetwork/ Twitter: https://twitter.com/medic_network LinkedIn: https://www.linkedin.com/company/that-medic-podcast/ Subscribe to our newsletter: https://doctorinprogress.com/ Contact us: info@thatmedicnetwork.com Hiring Position: https://linktr.ee/thatmedicnetwork

Nick Damiano is a serial entrepreneur with broad experience in medical devices and digital health. He has 15 years of experience as a healthcare entrepreneur, engineer, and leader. He is currently Co-Founder & CEO of Zenflow, which is developing a novel office-based therapy to relieve symptoms of benign prostatic hyperplasia (BPH), which affects over 500 million men globally. The company has raised over $40 million in funding and conducted successful clinical trials in four countries. Zenflow is backed by leading venture firms including Invus and F-Prime and was one of the first medical device companies funded by Y Combinator, the world’s leading startup accelerator. Prior to Zenflow, Nick was an Innovation Fellow at Stanford University. Before Biodesign, he co-founded Nurep (now called Avail MedSystems), a company developing telemedicine solutions for medical device procedures. In this role, Nick led the successful technical development effort to bring the company's product to market and also played key roles in strategy, sales, and fundraising. Prior to Nurep, he worked in engineering roles for several small medical device companies, including developing critical algorithms for the world’s first leadless cardiac pacing system at EBR Systems. Outside of Zenflow, Nick plays an active role in mentoring and advising medtech and healthcare entrepreneurs and startups. He has served as an advisor in various capacities at StartX, Y Combinator Startup School, Stanford Byers Center for Biodesign, and the Rosenman Institute. He is also a Venture Partner at Pioneer Fund, a venture fund led by Y Combinator alumni. Nick grew up on the east coast and earned his M.S. and B.S. with Distinction in Management Science & Engineering from Stanford University.

The topic: Needs-based innovation with Marta Zanchi, PhD.  Our guest: Marta is originally from Italy and spent 13 years at Stanford University, first as a doctoral student then as a faculty member and founding director of digital health at the Stanford Byers Center for Biodesign. Her experience spans from designing software and hardware devices to walking the full process of health technology innovation. Marta has advised companies, spent time as a medical device fellow at the FDA, invested in companies through her role as an Equity Partner at Palo Alto-based DCVC, and she recently relocated to Barcelona where she’s the founder and managing partner of health-tech microVC fund Nina Capital.  Links and Resources:Marta Zanchi: Twitter  •  LinkedinNina Capital:  Website  •  Twitter   •  LinkedIn   •   Stanford Byers Center for Biodesign on Twitter  •  LinkedIn  •  Web  •  Page Get more content:Browse episodes on Digital Health Today Follow us on Twitter @dhealthtoday, Linkedin, Facebook and InstagramGet the full show notes here.---Visit the Health Podcast Network Digital Health Today is made possible by the support of our sponsors. Thank you to Bayer G4A Cedars-Sinai Accelerator Dot Health Medable Ostendio Start-Up Nation Central  Learn more about your ad choices. Visit megaphone.fm/adchoices

Sponsored by CMO Coaches.Today, in the final installment of CMO Week on the MarTech Pod, we talk with Kelly Brezoczky, who is Founder and Executive Director at Healthy Mature Living Foundation and Guest Lecturer at Stanford Byers Center for Biodesign. Prior to her current roles, Kelly was CEO at Butterfly Health and Marketing Director at Proctor & Gamble. Show NotesConnect With: Kelly Brezoczky - Website // Twitter // Linkedin Benjamin Shapiro: Website // LinkedIn // TwitterSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Sponsored by CMO Coaches.Today, in the final installment of CMO Week on the MarTech Pod, we talk with Kelly Brezoczky, who is Founder and Executive Director at Healthy Mature Living Foundation and Guest Lecturer at Stanford Byers Center for Biodesign. Prior to her current roles, Kelly was CEO at Butterfly Health and Marketing Director at Proctor & Gamble. Show NotesConnect With: Kelly Brezoczky - Website // Twitter // Linkedin Benjamin Shapiro: Website // LinkedIn // Twitter

Amanda French, Co-Founder and CEO, Cadence Digital Amanda is the co-founder and CEO of Cadence Digital – a reproductive health company focused on empowering women to understand and control their birth control. She was a 2016-2017 Innovation Fellow at the Stanford Byers Center for Biodesign. Amanda began her career at Edwards Lifesciences, where through the Technical Development Program she gained experience in R&D, program management, manufacturing, and marketing. She quickly caught the innovation bug, and enjoyed developing breakthrough technology as an R&D engineer with Edwards' Advanced Technology teams as well as at Earlens. Amanda holds a BS in mechanical engineering from Duke University. When she is not working, she enjoys cooking, yoga, and contemporary dance.

Dr. Justin Barad is the CEO of Osso VR, a virtual reality surgical training software company. Justin and the team at Osso VR are developing a surgical training platform that uses virtual reality and gaming technology to solve critical training challenges for surgeons and healthcare providers around the world. In his free time, Justin enjoys sipping on a good cup of coffee, going for a run with his dog, and playing the piano and flute. He also enjoys traveling to new places around the world and exploring the local cuisine. He received his bachelor’s degree in bioengineering and biomedical engineering from the University of California, Berkeley and was awarded his MD from the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Afterwards, Justin completed his residency in orthopedics at UCLA and his fellowship in pediatric orthopaedics at Harvard University and Boston Children’s Hospital. Justin was subsequently awarded a Biodesign Innovation Fellowship at the Stanford Byers Center for Biodesign. In addition, Justin has been an editor and contributor for over a decade to the popular medical technology news site Medgadget. In our interview, Justin told us more about his life and science.

Michael Ackermann, CEO of a med-tech startup that created a tear-stimulation device for those with dry-eye disease, explains how acquisition by a global pharmaceutical giant is helping him achieve his goal of reaching as many patients as possible. Ackermann, a graduate of the Stanford Byers Center for Biodesign, also discusses why big tech companies have yet to disrupt healthcare and how that translates into big opportunities for entrepreneurs.

Michael Ackermann, CEO of a med-tech startup that created a tear-stimulation device for those with dry-eye disease, explains how acquisition by a global pharmaceutical giant is helping him achieve his goal of reaching as many patients as possible. Ackermann, a graduate of the Stanford Byers Center for Biodesign, also discusses why big tech companies have yet to disrupt healthcare and how that translates into big opportunities for entrepreneurs.

Michael Ackermann, CEO of a med-tech startup that created a tear-stimulation device for those with dry-eye disease, explains how acquisition by a global pharmaceutical giant is helping him achieve his goal of reaching as many patients as possible. Ackermann, a graduate of the Stanford Byers Center for Biodesign, also discusses why big tech companies have yet to disrupt healthcare and how that translates into big opportunities for entrepreneurs.

Over the last 15 years, Stanford Biodesign – now called the Stanford Byers Center for Biodesign - has trained more than 1,000 graduate students and nearly 200 fellows. In a new 1:2:1 podcast, Paul Yock, the Martha Meier Weiland Professor of Medicine, founding co-chair of Stanford’s Department of Bioengineering, and Biodesign’s director, discusses the program's success.